JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

GDF15 drives de novo lipogenesis and contributes to ovarian cancer metastasis

  • 0State Key Lab of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China.
Biochimica Et Biophysica Acta. Molecular Basis of Disease +

|

April 25, 2025

|

April 25, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Growth differentiation factor 15 (GDF15) is elevated in ovarian cancer patients and promotes metastasis by enhancing lipid metabolism via the PI3K/AKT pathway. Targeting GDF15 offers a potential therapeutic strategy against ovarian cancer spread.

Area Of Science

  • Oncology
  • Metabolic Research
  • Molecular Biology

Background

  • Ovarian cancer often presents at advanced stages with metastasis.
  • Non-mutational factors significantly influence cancer metastasis.
  • Altered lipid metabolism is a hallmark of cancer progression.

Purpose Of The Study

  • To investigate the role of growth differentiation factor 15 (GDF15) in ovarian cancer metastasis.
  • To explore the association between GDF15 levels and patient survival.
  • To elucidate the mechanism by which GDF15 influences tumor spread.

Main Methods

  • Serum analysis of GDF15 levels in ovarian cancer patients.
  • Correlation analysis between GDF15 levels and clinical outcomes (overall survival, progression-free survival).
  • Investigation of GDF15's effect on de novo lipogenesis and the PI3K/AKT pathway in tumor cells.

Main Results

  • GDF15 is significantly elevated in the serum of ovarian cancer patients, especially in metastatic lesions.
  • Higher GDF15 levels correlate with reduced overall and progression-free survival.
  • GDF15 promotes ovarian cancer metastasis by upregulating de novo lipogenesis through the PI3K/AKT signaling pathway.

Conclusions

  • GDF15 is a potential biomarker for advanced ovarian cancer and poor prognosis.
  • GDF15 plays a critical role in facilitating ovarian cancer metastasis.
  • Targeting GDF15-mediated lipid metabolism presents a novel therapeutic avenue for inhibiting ovarian cancer metastasis.

Keywords: